Based on the previous univariate COX prognostic analysis, TME analysis, and immune infiltration analysis conducted within the pan-cancer scope, all of which demonstrated the value of CILP2 in PAAD, we further explored the expression profile of CILP2 in PDAC (the most common and typical type of pancreatic cancer). This evidence concerns the gene CILP2 and pancreatic adenocarcinoma.